A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 10, 2001, Pages 1815-1828

  Prabhakar, Rethinasamy ^a   Boivin, Greg P ^a   Grupp, Ingrid L ^a   Hoit, Brian ^b   Arteaga, Grace ^c   Solaro, R John ^c   Wieczorek, David F ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cardiac hypertrophy; Familial hypertrophic cardiomyopathy; Sarcomeric function; Transgenic mice; Tropomyosin

Indexed keywords

ACTIN; ALPHA TROPOMYOSIN; CONTRACTILE PROTEIN; MUTANT PROTEIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; TROPOMYOSIN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FAMILIAL DISEASE; GENE EXPRESSION; HEART HYPERTROPHY; HISTOPATHOLOGY; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SARCOMERE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0034781383     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2001.1445     Document Type: Article

References (29)

1. Familial hypertrophic cardiomyopathy
2. The management of hypertrophic cardiomyopathy
3. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy
4. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
5. Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy
6. Familial hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (val95ala) is associated with mild cardiac hypertrophy but a high incidence of sudden death
7. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha-tropomyosin (asp175asn and glu180gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay
8. Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function
9. Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies
10. Mouse model of a familial hypertrophic cardiomyopathy mutation in α-tropomyosin manifests cardiac dysfunction
11. Chromosomal localization and genomic cloning of the mouse α-tropomyosin gene Tpm-1
12. Molecular and physiological effects of overexpressing striated muscle β-tropomyosin in the adult murine heart
13. Monoclonal antibodies against chicken tropomyosin isoforms: Production, characterization, and application
14. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency
15. Echocardiographic assessment of left ventricular mass and systolic function in mice
16. 2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express β-tropomyosin
17. Molecular and physiological effects of α-tropomyosin ablation in the mouse
18. Targeted ablation of the murine α-tropomyosin gene
19. β-Tropomyosin overexpression induces severe cardiac abnormalities
20. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes
21. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity
22. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene
23. Novel mutation in the α-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy
24. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy
25. The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population
26. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene
27. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2
28. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy
29. Conformational parameters for amino acids in helical. β-sheet, and random coil regions calculated from proteins